RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/23764004http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/23764004http://www.w3.org/2000/01/rdf-schema#comment"B cell receptor (BCR) signaling pathway components represent promising treatment targets in diffuse large B cell lymphoma (DLBCL) and additional B cell tumors. BCR signaling activates spleen tyrosine kinase (SYK) and downstream pathways including PI3K/AKT and NF-κB. In previous studies, chemical SYK blockade selectively decreased BCR signaling and induced apoptosis of BCR-dependent DLBCLs. Herein, we characterize distinct SYK/PI3K-dependent survival pathways in DLBCLs with high or low baseline NF-κB activity including selective repression of the pro-apoptotic HRK protein in NF-κB-low tumors. We also define SYK/PI3K-dependent cholesterol biosynthesis as a feed-forward mechanism of maintaining the integrity of BCRs in lipid rafts in DLBCLs with low or high NF-κB. In addition, SYK amplification and PTEN deletion are identified as selective genetic alterations in primary "BCR"-type DLBCLs."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.org/dc/terms/identifier"doi:10.1016/j.ccr.2013.05.002"xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Chen L."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Ouyang J."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Monti S."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Kutok J.L."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Neuberg D."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Dogan A."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Chapuy B."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Doench J.G."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Juszczynski P."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Shipp M.A."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Rodig S.J."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Golub T."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Witzig T.E."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Habermann T.M."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/author"Bogusz A.M."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/date"2013"xsd:gYear
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/name"Cancer Cell"xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/pages"826-838"xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/title"SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas."xsd:string
http://purl.uniprot.org/citations/23764004http://purl.uniprot.org/core/volume"23"xsd:string
http://purl.uniprot.org/citations/23764004http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/23764004
http://purl.uniprot.org/citations/23764004http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/23764004